184 related articles for article (PubMed ID: 24535238)
1. International ring trial of the epidermal equivalent sensitizer potency assay: reproducibility and predictive-capacity.
Teunis MA; Spiekstra SW; Smits M; Adriaens E; Eltze T; Galbiati V; Krul C; Landsiedel R; Pieters R; Reinders J; Roggen E; Corsini E; Gibbs S
ALTEX; 2014; 31(3):251-68. PubMed ID: 24535238
[TBL] [Abstract][Full Text] [Related]
2. An epidermal equivalent assay for identification and ranking potency of contact sensitizers.
Gibbs S; Corsini E; Spiekstra SW; Galbiati V; Fuchs HW; Degeorge G; Troese M; Hayden P; Deng W; Roggen E
Toxicol Appl Pharmacol; 2013 Oct; 272(2):529-41. PubMed ID: 23876969
[TBL] [Abstract][Full Text] [Related]
3. A potential in vitro epidermal equivalent assay to determine sensitizer potency.
dos Santos GG; Spiekstra SW; Sampat-Sardjoepersad SC; Reinders J; Scheper RJ; Gibbs S
Toxicol In Vitro; 2011 Feb; 25(1):347-57. PubMed ID: 20940038
[TBL] [Abstract][Full Text] [Related]
4. Assessment of metal sensitizer potency with the reconstructed human epidermis IL-18 assay.
Gibbs S; Kosten I; Veldhuizen R; Spiekstra S; Corsini E; Roggen E; Rustemeyer T; Feilzer AJ; Kleverlaan CJ
Toxicology; 2018 Jan; 393():62-72. PubMed ID: 29079364
[TBL] [Abstract][Full Text] [Related]
5. Development of an in vitro method to estimate the sensitization induction level of contact allergens.
Galbiati V; Papale A; Marinovich M; Gibbs S; Roggen E; Corsini E
Toxicol Lett; 2017 Apr; 271():1-11. PubMed ID: 28189648
[TBL] [Abstract][Full Text] [Related]
6. Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency.
Teunis M; Corsini E; Smits M; Madsen CB; Eltze T; Ezendam J; Galbiati V; Gremmer E; Krul C; Landin A; Landsiedel R; Pieters R; Rasmussen TF; Reinders J; Roggen E; Spiekstra S; Gibbs S
Toxicol In Vitro; 2013 Apr; 27(3):1135-50. PubMed ID: 22728231
[TBL] [Abstract][Full Text] [Related]
7. Skin Sensitization Tests: The LLNA and the RhE IL-18 Potency Assay.
Corsini E; Gibbs S; Roggen E; Kimber I; Basketter DA
Methods Mol Biol; 2021; 2240():13-29. PubMed ID: 33423223
[TBL] [Abstract][Full Text] [Related]
8. Does the extreme skin sensitization potency of benzoquinone result from special chemistry?
Roberts DW; Aptula AO
Contact Dermatitis; 2009 Dec; 61(6):332-6. PubMed ID: 20059493
[TBL] [Abstract][Full Text] [Related]
9. Human potency predictions for aldehydes using the local lymph node assay.
Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
[TBL] [Abstract][Full Text] [Related]
10. Prediction of skin sensitization potency using machine learning approaches.
Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
[TBL] [Abstract][Full Text] [Related]
11. Reproducible prediction of contact allergenic potency using the local lymph node assay.
Basketter DA; Cadby P
Contact Dermatitis; 2004 Jan; 50(1):15-7. PubMed ID: 15059097
[TBL] [Abstract][Full Text] [Related]
12. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
Aptula AO; Patlewicz G; Roberts DW; Schultz TW
Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
[TBL] [Abstract][Full Text] [Related]
13. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
14. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
Roberts DW; Patlewicz G
J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
[TBL] [Abstract][Full Text] [Related]
15. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
[TBL] [Abstract][Full Text] [Related]
16. The inter-laboratory validation study of EpiSensA for predicting skin sensitization potential.
Mizumachi H; Watanabe M; Ikezumi M; Kajiwara M; Yasuda M; Mizuno M; Imai N; Sakuma M; Shibata M; Watanabe SI; Motoyama J; Basketter D; Eskes C; Hoffmann S; Lehmann DM; Ashikaga T; Sozu T; Takeyoshi M; Suzuki S; Miyazawa M; Kojima H
J Appl Toxicol; 2024 Apr; 44(4):510-525. PubMed ID: 37897225
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
[TBL] [Abstract][Full Text] [Related]
18. Predictive identification of human skin sensitization thresholds.
Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
[TBL] [Abstract][Full Text] [Related]
19. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
20. Development of an In Vitro Method to Estimate the Sensitization Induction Level of Contact Allergens.
Galbiati V; Gibbs S; Roggen E; Corsini E
Curr Protoc Toxicol; 2018 Feb; 75():20.15.1-20.15.20. PubMed ID: 29512124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
